Stem Medica India Blogs

Advances in Stem Cell Therapy in Case of Diabetes Mellitus at Stemmedica India

Advances in Stem Cell Therapy in Case of Diabetes Mellitus at Stemmedica India.

Diabetes is defined as inability of body to produce or to respond /utilize insulin resulting abnormal metabolism of carbohydrates which increase blood glucose level.

In case of type 2 diabetes mellitus insulin production by beta cells of Pancreas is normal but muscles are incompetent to use that insulin against glucose.

Pathophysiology of Diabetes:

Complications of Diabetes:

Stem cell Clinical Trials for Diabetes: Publications of Research Paper.

Which Stem cells are used for Type 2 Diabetes?

Autologous Stem Cell Therapy (from Patient body): Bone Marrow & Adipose /Fat Stem Cells, Venous Blood Platelet rich Plasma.

Allogeneic Stem Cell Therapy: Umbilical Cord tissue Mesenchymal Stem Cells.

How shall procedure done:

Bone marrow Harvest: 100ml Bone marrow harvested from iliac crest under local anesthesia & intravenous Sedation.

Processing of Stem Cells: by minimal manipulation both bone marrow & blood PRP processed.

Re administration: systemic & local.

Intravenously, into Pancreatic or hepatic artery, Subcutaneously..

Quick Enquiry

© 2019 Stem Medica India. All Rights Reserved | Design by Webang Team